GlassScriptPhysician profile
Lisa M Greene
NPI 1134147093
$186,285.14
in general payments reported to CMS, 2019-2025
17 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $13K · 2021: $37K · 2022: $41K · 2023: $24K · 2024: $6,724 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $15K · Consulting Fee: $6,838 · Food and Beverage: $4,655 · Entertainment: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,805.00 |
| Travel and Lodging | $15,016.65 |
| Consulting Fee | $6,837.50 |
| Food and Beverage | $4,655.26 |
| Entertainment | $180.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $180,601.99 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Alcon Research LLC | $2,397.14 | 2019 | |
| Coopervision INC. | $857.92 | 2021-2025 | Synergeyes Contact Lens, Onefit Contact Lens, Misight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $603.54 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $449.24 | 2022-2025 | Infuse, Vyzulta |
| Optos, INC. | $272.88 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $259.63 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $203.01 | 2019-2023 | Acuvue |
| Rxsight INC | $141.37 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Glaukos Corporation | $133.11 | 2021-2025 | Photrexa Viscous and Photrexa |
| Abb Con-Cise Optical Group LLC | $131.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $64.05 | 2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Lumenis, INC | $54.49 | 2021 | |
| Maculogix, INC. | $44.12 | 2020 | |
| Konan Medical USA, INC. | $31.01 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $20.79 | 2025 | Xdemvy |
| Lombart Brothers, INC. | $18.90 | 2025 | Opd-III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.